CISPLATIN NEPHROTOXICITY - A SUMMARY OF PREVENTATIVE INTERVENTIONS

被引：33

作者：

FINLEY, RS ^{[1
]}

FORTNER, CL ^{[1
]}

GROVE, WR ^{[1
]}

机构：

[1] NCI,DCT,CTEP,INVEST DRUG BRANCH,DRUG MANAGEMENT & AUTHORIZAT SECT,BETHESDA,MD 20205

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1985年 / 19卷 / 05期

关键词：

D O I：

10.1177/106002808501900505

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：362 / 367

页数：6

共 47 条

[1]

ALSARRAF M, 1982, CANCER TREAT REP, V66, P31

[2]

BHUCHAR VK, 1982, CANCER TREAT REP, V66, P375

[3] RENAL AND ELECTROLYTE DISTURBANCES ASSOCIATED WITH CISPLATIN [J].

BLACHLEY, JD ;

HILL, JB .

[4]

CVITKOVIC E, 1977, CANCER, V39, P1357, DOI 10.1002/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO

[5]

2-C

[6]

DENTINO M, 1978, CANCER, V41, P1274, DOI 10.1002/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO

[7]

2-F

EINHORN, LH ;

DONOHUE, J .

EINHORN, LH ;

WILLIAMS, SD .

[10]

FRICK GA, 1979, CANCER TREAT REP, V63, P13